Predictors of histologic response to mepolizumab in pediatric eosinophilic esophagitis.

Background: Eosinophilic esophagitis (EoE) is a chronic, allergic disease of the esophagus. Current treatment options are limited. One experimental therapy is antibodies against interleukin-5 (IL-5).